OXAGON
🇮🇳India
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)The Efficacy of Topical Vaginal Oxytocin Gel in Postmenopausal Women With Vulvovaginal Atrophy
Phase 3
Not yet recruiting
- Conditions
- Genitourinary Syndrome of MenopauseVulvar AtrophyVaginal Atrophy
- Interventions
- Other: Hydroxypropyl methylcellulose
- First Posted Date
- 2024-07-23
- Last Posted Date
- 2024-07-23
- Lead Sponsor
- Oxagon
- Target Recruit Count
- 244
- Registration Number
- NCT06514586
- Locations
- 🇪🇬
Oxagon, Cairo, Egypt
News
No news found